Ocugen

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon

MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More
Grants

Pennsylvania Pledges $6.5 Million to Expand Essential Services for Individuals Battling Substance Use Disorders

HARRISBURG, PA — The Department of Drug and Alcohol Programs (DDAP) has taken a significant stride towards combating substance use disorders (SUD), announcing the availability of $6.5 million in funding. …

Pennsylvania Pledges $6.5 Million to Expand Essential Services for Individuals Battling Substance Use Disorders Read More